Trial Profile
A single arm, intergroup study of Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms EsPhALL 2010-2014
- 04 Jan 2018 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology